Hipolin Ltd Upgraded to Sell as Technicals Improve Amid Mixed Financials

Technical Trends Shift to Mildly Bullish

The primary catalyst for the upgrade stems from a positive shift in Hipolin’s technical profile. The company’s technical grade moved from a sideways trend to mildly bullish, supported by mixed but improving momentum indicators. On a weekly basis, the Moving Average Convergence Divergence (MACD) remains mildly bearish, but the monthly MACD has turned mildly bullish, suggesting emerging upward momentum over the medium term.

Other technical signals present a similarly mixed picture. The Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts, indicating a neutral momentum stance. Bollinger Bands reveal a mildly bearish trend weekly but a mildly bullish trend monthly, reinforcing the notion of a nascent recovery. Daily moving averages have turned mildly bullish, further supporting short-term positive price action.

However, some caution is warranted as the On-Balance Volume (OBV) remains bearish on both weekly and monthly timeframes, indicating that volume trends have yet to confirm the price strength fully. The KST oscillator and Dow Theory signals also reflect this duality, with weekly mildly bearish and monthly mildly bullish readings.

These technical nuances have contributed to a 4.99% gain in the stock price on the day of the rating change, closing at ₹83.46, up from the previous close of ₹79.49. The stock remains well below its 52-week high of ₹118.80 but comfortably above its 52-week low of ₹44.83, reflecting a recovery phase.

Financial Trend: Mixed Signals Amidst Weak Long-Term Growth

Despite the technical improvements, Hipolin’s financial fundamentals remain under pressure. The company reported positive quarterly results for Q1 FY26-27, with net sales reaching a quarterly high of ₹5.20 crores. Profit before tax (excluding other income) was recorded at ₹-0.03 crores, and profit after tax stood at ₹0.02 crores, marking the highest quarterly PAT in recent periods. These figures indicate a modest recovery in profitability.

However, the long-term financial trend is less encouraging. Hipolin’s net sales have contracted at a compound annual growth rate (CAGR) of -0.25% over the past five years, signalling stagnation or decline in core business growth. The company’s ability to service debt is notably weak, with an average EBIT to interest ratio of -1.59, reflecting operational losses relative to interest obligations.

Moreover, the company recorded a negative EBITDA of ₹-0.04 crores, underscoring ongoing operational challenges. While profits have surged by 99.3% over the past year, this improvement is from a very low base, and the stock’s one-year return of -3.23% lags behind the broader Sensex decline of -9.29% over the same period.

Valuation and Market Capitalisation Considerations

Hipolin is classified as a micro-cap stock, which inherently carries higher volatility and risk. The stock’s current price of ₹83.46 reflects a premium over its 52-week low but remains significantly below its 52-week high, suggesting that the market is still cautious about the company’s prospects.

Valuation metrics indicate that the stock is trading at a risky level compared to its historical averages. This elevated risk profile is compounded by the company’s negative EBITDA and weak long-term sales growth. Investors should weigh these valuation concerns against the recent technical improvements and quarterly financial gains.

Quality Assessment and Promoter Confidence

Hipolin’s overall quality grade remains low, consistent with its Sell rating and a Mojo Score of 39.0. The previous grade was Strong Sell, indicating a slight improvement but still reflecting significant fundamental weaknesses.

One notable positive is the rising promoter confidence. Promoters have increased their stake by 9.37% over the previous quarter, now holding 69.59% of the company’s equity. This substantial increase signals strong insider belief in the company’s future prospects, which may provide some reassurance to investors amid the challenging operating environment.

Comparing Hipolin’s returns to the Sensex over various timeframes reveals a mixed performance. The stock outperformed the Sensex over the past week with an 8.4% gain versus 0.71% for the benchmark. However, it underperformed over the one-month period (-10.74% vs. -3.88%) and year-to-date (Sensex down 12.55%, Hipolin data not available). Over five years, Hipolin has delivered a robust 59.73% return compared to Sensex’s 26.48%, highlighting some long-term value creation despite recent struggles.

Investment Outlook: Cautious Optimism Amid Risks

The upgrade of Hipolin Ltd’s rating from Strong Sell to Sell reflects a cautious optimism driven primarily by technical improvements and increased promoter confidence. The mildly bullish technical indicators suggest that the stock may be entering a recovery phase, supported by recent positive quarterly results.

Nevertheless, investors should remain wary of the company’s weak long-term fundamentals, including negative EBITDA, poor debt servicing capacity, and stagnant sales growth. The micro-cap status adds an additional layer of risk due to lower liquidity and higher volatility.

For investors considering Hipolin, the key will be monitoring whether the technical momentum can translate into sustained financial improvement and whether promoter confidence is matched by operational execution. Until then, the Sell rating reflects a balanced view acknowledging both the potential for recovery and the significant risks that remain.

Summary of Ratings and Scores

As of 22 September 2026, Hipolin Ltd holds a Mojo Score of 39.0 with a Sell grade, upgraded from Strong Sell. The company remains a micro-cap within the FMCG sector. Technical grades have improved from sideways to mildly bullish, while financial trends and quality assessments remain weak. The stock’s recent day change of +4.99% reflects positive market reaction to these developments.

Key Data Points at a Glance:

• Current Price: ₹83.46
• Previous Close: ₹79.49
• 52-Week High/Low: ₹118.80 / ₹44.83
• Promoter Holding: 69.59% (up 9.37% QoQ)
• Net Sales Q1 FY26-27: ₹5.20 crores (highest quarterly)
• EBIT to Interest Ratio (avg): -1.59
• EBITDA: ₹-0.04 crores (negative)
• 1-Year Stock Return: -3.23%
• 5-Year Stock Return: +59.73%

Investors should continue to monitor Hipolin’s evolving technical signals and financial results to assess whether the recent upgrade marks the beginning of a sustained turnaround or a temporary reprieve in an otherwise challenging environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →